Martina Marangoni

Martina Marangoni

Auto-generated profile, based on publicly available information

Martina Marangoni

Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Biological Psychiatry
Verified
Journal Article
Closed access
BJBrett V. Johnson
Brett V. Johnson
RKRaman Kumar
Raman Kumar
SOSabrina Oishi
Sabrina Oishi
SASuzy Alexander
Suzy Alexander
MKMaria Kasherman
Maria Kasherman
LJLachlan Jolly
Lachlan Jolly

1 February 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
MMMartina Marangoni
Martina Marangoni
GSGuillaume Smits
Guillaume Smits
GCGilles Ceysens
Gilles Ceysens
ECElena Costa
Elena Costa
RCRobert Coulon
Robert Coulon
IMIsabelle Migeotte
Isabelle Migeotte

1 April 2020 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
CGCeline De Graer
Celine De Graer
MMMartina Marangoni
Martina Marangoni
SRStephanie Romnée
Stephanie Romnée
MDMélanie Delaunoy
Mélanie Delaunoy
SZSiham Zaytouni
Siham Zaytouni
CDCatherine Donner
Catherine Donner

1 December 2020 in F&S Reports
Verified
Journal Article
Open access
ASAsma Sassi
Asma Sassi
JDJulie Désir
Julie Désir
VJVéronique Janssens
Véronique Janssens
MMMartina Marangoni
Martina Marangoni
DDDorien Daneels
Dorien Daneels
ADAnne Delbaere
Anne Delbaere
To find the genetic etiology of premature ovarian insufficiency (POI) in a patient with primary amenorrhea and hypergonadotropic hypogonadism. Case report. University hospital. A Belgian woman aged 32 years with POI at the age of 17, her parents, and her sister whose POI was diagnosed at age 29. Analysis of a panel of 31 genes implicated in POI (POIGP) using next-generation sequencing (NGS), Sanger sequencing, and in vitro functional study. Gene variants, family mutational segregation, and in vitro functional impact of the mutant proteins. The analysis of the gene panel using NGS identified the presence of two novel follicle-stimulating hormone receptor (FSHR) missense mutations at a compound heterozygous state in the affected patient: c.646 G>A, p.Gly216Arg, and c.1313C>T, p.Thr438Ile. Sanger sequencing showed the presence of each mutation at heterozygous state in the patient’s parents and at heterozygous compound state in the affected sister. Both substituted amino acids (Gly216 and Thr438) were conserved in FSHR of several vertebrate species as well as in other glycoproteins receptors (TSHR and LHCGHR), suggesting a potentially important role in glycoprotein receptor function. An in vitro functional study showed similar results for both variants with more than 90% reduction of their cell surface expression and a 55% reduction of their FSH-induced cyclic adenosine 3′:5′ monophosphate (cAMP) production compared with the wild-type FSHR. The analysis of a gene panel of 31 genes implicated in POI allowed us to identify two novel partially inactivating mutations of FSHR that are likely responsible for the POI phenotype of the proband and of her affected sister.

10 December 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
GGGiuseppe Gambino
Giuseppe Gambino
CCConcetta Catalano
Concetta Catalano
MMMartina Marangoni
Martina Marangoni
CGCaroline Geers
Caroline Geers
AMAlain Le Moine
Alain Le Moine
LGLidia Ghisdal
Lidia Ghisdal
Background: Ciliopathies are rare diseases causing renal and extrarenal manifestations. Here, we report the case of a ciliopathy induced by a homozygous pathogenic variant in the TTC21B gene.Case Description: A 47-year-old patient started hemodialysis for chronic kidney disease (CKD) of unknown origin. She presented with early onset of hypertension, pre-eclampsia, myopia and cirrhosis. Renal biopsy showed mild interstitial fibrosis, tubular atrophy, and moderate arteriosclerosis while liver pathology demonstrates grade B biliary cirrhosis. Family history revealed several cases of early-onset severe hypertension and one case of end-stage renal disease (ESRD) needing kidney transplantation at twenty years of age. Clinical exome sequencing showed homozygosis for the pathogenic variant c.626C>T (p.Pro209Leu) in the TTC21B gene. The patient underwent combined liver-renal transplantation with an excellent renal and hepatic graft outcome.Conclusions:TTC21B gene mutations can lead heterogeneous to clinical manifestations and represent an underappreciated cause of ESRD. The paradigm in diagnosis of CKD of early onset and/or of unknown origin is changing and genetic counseling should be performed in all patients and families that meet those criteria. Renal or combined liver-renal transplantation represents the best option for patients suffering from those diseases in terms of prognosis and quality of life.

1 July 2020 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
CGCaroline Gounongbé
Caroline Gounongbé
MMMartina Marangoni
Martina Marangoni
VBVanessa Gouder de Beauregard
Vanessa Gouder de Beauregard
MDMélanie Delaunoy
Mélanie Delaunoy
PJPatrice Jissendi
Patrice Jissendi
JDJulie Désir
Julie Désir
We present a case of a middle interhemispheric variant of antenatal discovery associated with a de novo missense variant (NM_007129.5: c.1109G>A p.(Cys370Tyr)) in the ZIC2 gene. Our case represents the first prenatal description of a ZIC2 missense mutation found in association with syntelencephaly.